Vector-borne diseases (VBDs) like malaria, dengue, Zika, and Japanese encephalitis are major public health threats, causing millions of infections and over 700,000 deaths annually. Transmitted by vectors such as mosquitoes, ticks, and flies, these diseases require rapid and accurate diagnosis for effective control.

In-vitro diagnostic (IVD) real-time PCR (RT-PCR) kits have become essential in diagnosing VBDs. These kits quickly and accurately identify pathogen genetic material from clinical samples, providing reliable results with high sensitivity and specificity. This accuracy is crucial for timely and effective treatment.

G2M offers CE-IVD-approved RT-PCR kits specifically for VBD diagnosis. These kits are highly sensitive and specific, compatible with common PCR instruments, and show no cross-reactivity with other pathogens, ensuring accurate diagnoses.

G2M RT-PCR kits use specific primers, fluorescent probes to target pathogen RNA or DNA, and internal control (IC). This setup, involving fluorescent reporter and quencher dyes, ensures precise detection and supports timely medical and public health responses.